134 related articles for article (PubMed ID: 144558)
21. Effects of 8-azaadenosine and formycin on cell lethality and the synthesis and methylation of nucleic acids in human colon carcinoma cells in culture.
Glazer RI; Lloyd LS
Biochem Pharmacol; 1982 Oct; 31(20):3207-14. PubMed ID: 7150349
[TBL] [Abstract][Full Text] [Related]
22. [Characteristics of the catabolic and anabolic transformations of nucleic acids in the ascitic cells of Zajdela hepatoma and in suspensions of normal liver cells].
Vornovitskaia GI; Ioannesiants IA; Shapot VS
Vopr Med Khim; 1974; 20(2):182-7. PubMed ID: 4375348
[No Abstract] [Full Text] [Related]
23. Antitumor activity of pyrazofurin in combination with 5-azacytidine against murine P388 and L1210 leukemias and colon carcinoma 26.
Chiuten DF; Muggia FM; Johnson RK
Cancer Treat Rep; 1979; 63(11-12):1857-62. PubMed ID: 93512
[No Abstract] [Full Text] [Related]
24. Tumor 5-fluorodeoxyuridylate concentration as a determinant of 5-fluorouracil response.
Ardalan B; Buscaglia MD; Schein PS
Biochem Pharmacol; 1978; 27(16):2009-13. PubMed ID: 718724
[No Abstract] [Full Text] [Related]
25. [Nucleic acid metabolism in hepatoma 46 and normal liver].
Bogdanov GN; Shmonina VM
Ukr Biokhim Zh; 1974; 46(2):181-4. PubMed ID: 4363993
[No Abstract] [Full Text] [Related]
26. [Development of fluoropyrimidine derivatives].
Fujii S; Shirasaka T
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2316-28. PubMed ID: 6238573
[TBL] [Abstract][Full Text] [Related]
27. Beta-aminoisobutyric acid, a new probe for the metabolism of DNA and RNA in normal and tumorous tissue.
Nielsen HR; Sjolin KE; Nyholm K; Baliga BS; Wong R; Borek E
Cancer Res; 1974 Jun; 34(6):1381-4. PubMed ID: 4363656
[No Abstract] [Full Text] [Related]
28. Determination of individual human tumour sensitivity to antitumour agents by tissue-slice incubation.
Willoughby HW; Maughan GB; Tremblay PC; Wood N
Can J Surg; 1971 Nov; 14(6):406-9. PubMed ID: 5170129
[No Abstract] [Full Text] [Related]
29. [Mechanism of the antitumor action of 5-fluorouracil].
Reztsova VV; Filov VA; Stukov AN
Dokl Akad Nauk SSSR; 1980; 253(2):488-91. PubMed ID: 7428592
[No Abstract] [Full Text] [Related]
30. [On the question of preclinical selection of cytostatics in the area of treatment of human tumors].
Wüst GP
Arzneimittelforschung; 1969 May; 19(5):817-9. PubMed ID: 4184536
[No Abstract] [Full Text] [Related]
31. A comparison of the rate of recovery from inhibition of RNA synthesis in mouse liver and transplantable glioma.
Yarbro JW; Kennedy BJ
Cancer Res; 1967 Oct; 27(10):1779-82. PubMed ID: 6064957
[No Abstract] [Full Text] [Related]
32. Biochemical aspects of the interactions of the teratogens 5-fluorouracil and 5-fluorodeoxyuridine with normal nucleic acid precursors in mice selected for low and high expression of Strong's luxoid gene.
Forsthoefel PF; Blend MJ; Snow JW
Teratology; 1978 Oct; 18(2):269-76. PubMed ID: 152484
[No Abstract] [Full Text] [Related]
33. Dual effects of pyrazofurin and 3-deazauridine upon pyrimidine and purine biosynthesis in mouse L1210 leukemia.
Sant ME; Lyons SD; Kemp AJ; McClure LK; Szabados E; Christopherson RI
Cancer Res; 1989 May; 49(10):2645-50. PubMed ID: 2713848
[TBL] [Abstract][Full Text] [Related]
34. Uracil enhancement of 5-fluorodexoyuridine incorporation into human breast carcinoma deoxyribonucleic acid.
Kufe DW; Herrick D; Gunner L
Biochem Pharmacol; 1984 Jul; 33(14):2329-31. PubMed ID: 6235814
[No Abstract] [Full Text] [Related]
35. Biochemical modulation of fluorouracil by dipyridamole: preclinical and clinical experience.
Grem JL
Semin Oncol; 1992 Apr; 19(2 Suppl 3):56-65. PubMed ID: 1557658
[TBL] [Abstract][Full Text] [Related]
36. Uridine and cytidine metabolism following inhibition of de novo pyrimidine synthesis by pyrazofurin.
Cadman E; Benz C
Biochim Biophys Acta; 1980 Oct; 609(3):372-82. PubMed ID: 7437431
[TBL] [Abstract][Full Text] [Related]
37. FT-IR microscopic characterization of normal and malignant human colonic tissues.
Salman A; Argov S; Ramesh J; Goldstein J; Sinelnikov I; Guterman H; Mordechai S
Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL159-66. PubMed ID: 11936863
[TBL] [Abstract][Full Text] [Related]
38. Selectivity of action of 5-FU: biochemical basis.
Rustum YM; Danhauser L; Wang G
Bull Cancer; 1979; 66(1):43-7. PubMed ID: 154352
[TBL] [Abstract][Full Text] [Related]
39. Enhanced therapeutic efficacy of 5'deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolising enzymes.
Peters GJ; Braakhuis BJ; de Bruijn EA; Laurensse EJ; van Walsum M; Pinedo HM
Br J Cancer; 1989 Mar; 59(3):327-34. PubMed ID: 2522792
[TBL] [Abstract][Full Text] [Related]
40. [Use of biochemical criteria in the prognosis of the efficacy of chemotherapy in tumors].
Gerasimova GK; Matveev LV; Mokina VD
Vestn Akad Med Nauk SSSR; 1981; (12):15-9. PubMed ID: 7331487
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
